NHS National Pharmaceuticals - Everolimus and terminated agreement products

Contract summary

Industry

• Pharmaceutical products - 33600000

Location of contract

WA7 2ES

Value of contract

£7,403,286

Procurement reference

CF-0169000D0O000000rwimUAA1

Published date

9 April 2021

Closing date

26 April 2021

Closing time

1pm

Contract start date

15 May 2021

Contract end date

1 March 2022

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

This is an accelerated procedure.

Justification

This requirement to call for competition came about due to:\r

i). the availability of competitive supply in circumstances relating to intellectual property rights that could not have been foreseen and/or acted upon by the authority using regular tender timescales, and\r

ii). suppliers terminating existing agreements for critical care medicines where there remains an ongoing requirement to procure these medicines.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

---

Description

Tender Close: 26th April, 13:00.
Invitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement products
Offer reference number: CM/PHG/21/5632
Period of framework agreement: Start date to be confirmed with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Potential periods of call-offs under the framework agreement:

Everolimus: All regions: to commence as soon as possible with an end date of 01/03/2022
Oral Products: All regions: to commence as soon as possible with an end date of 28/02/2022
Hospital Only Products: DLS, DNE, DNW, DLN and DSW regions: to commence as soon as possible with an end date 31/01/2022

---

More information

Links

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLka/Q9R6UvHRLYxSRiKFFoAKGgv8t_vUHLtnAcPXCosQUlk
• Document No. 00 - Read Me First Document - Everolimus

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkz/df3zKmJ7mlf7AJof3o7ejJTpthwxvNpq8CoSxJrfMps
• Document No. 07a - Quality control technical sheet

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkf/aa.c0jLqkn7Jkm2Clt0rNVWe91LIVvPrm95J2v_0AUA
• Document No. 01 - Invitation to offer covering letter

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkk/AqnLTNbSiXBuPLMNF1RmF2uUA6BMxQWjqjUtiz.IOz0
• Document No. 02 - Terms of offer

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkh/N.ngD0FFcr2_.8o6ydbAPU5pjmYH6u_CDWslqNCp7fQ
• Document No. 05a (v) Product Listing & Usage - Hospital Only Products CM_PHG_21_5632_02

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLku/NXDYgLz3iwb6gBxsCBRIqaMwN7TMtKDER0Xr9t1BOaE
• Document No. 05b - Selectt offer schedule instructions

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkp/ah6w_KrHQyhJsXTkdfzKJLkE556DYVR.BCeHDSyYunA
• Document No. 03 - Framework Agreement and Terms and Conditions

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkl/OpfXYhW0hFEHSZNuvsKHP1Y2PKDRvT03X3uYVa8fXgI
• Document No. 04 - Contract technical specification

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkg/khmtJiVSTjD9NfUPJBstfaF5ssV_PbrLx7lO7AGEhjo
• Document No. 05a (ii), 05a (iv), 05a (vi) CM_PHG_21_5632 SELECTT Application

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkm/qbdByrJNHur91cEbIjwAwKkHpNPKQJVhtgfrMAfkXfs
• Document No. 05a (i) Product Listing & Usage - Everolimus CM_PHG_21_5632_00

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkn/3Uqdn9uozzwdz77pQ9x6MbwYJ3O8ShE0yzFY25K2N.M
• Document No. 05a (iii) Product Listing & Usage - Oral (plus non-parenteral) products CM_PHG_21_5632_01

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLl4/oLiz.eGY8KAak1HgYLIbVEIVH80KPHZyfyIT1EzbJmo
• Document No. 08 - Confidential information schedule

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLl5/4C4KS_U1lHnBEKe8mIa20v3AOvNKEiuEgJGeTXr8A.s
• FTS Notice - NHS National Pharmaceuticals - Everolimus and terminated agreement products

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkb/d.hnrkbP90kLLalIRykdP9rRZ7r1wNiRi_UosE9Phs4
• Document No. 06 - Form of offer

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLko/vFBvJs87O6C6bId1CEx6Y8xIErG7bfdqJChOdiUF8bA
• Document No. 07b - Guidance for Performing a Pharmaceutical Quality Assessment of Licensed Medicines for the NHS

---

About the buyer

Contact name

Gemma Tomlinson

Address

2nd Floor Rutland House
Runcorn
WA7 2ES
UK

Email

gemma.tomlinson1@nhs.net